Ruojia Li leads the Quantitative Sciences & Digital Transformation group within the Biologics Development organization at Bristol-Myers Squibb. Her team is responsible for CMC statistics, data science, clinical method performance monitoring, and manages digital transformation efforts across the organization. Ruojia holds a bachelor’s in Mathematics from Peking University, and a Ph.D. in Statistics from University of WisconsinMadison.